Utama › Limfoma Sel-B › Tennessee › Nashville
Kajian klinikal Limfoma Sel-B di Nashville, TN
11 kajian untuk Limfoma Sel-B sedang mencari peserta di lokasi dalam dan sekitar Nashville (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Mengambil pesertaFasa 1/2
- Sarah Cannon Research Institute, Nashville
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Mengambil pesertaFasa 3
- Tennessee Oncology Nashville St Thomas Midtown Clinic, Nashville
- Tennessee Oncology, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Mengambil pesertaFasa 1
- SCRI Oncology Partners, Nashville
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Mengambil pesertaFasa 2
- Research Site, Nashville
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Mengambil pesertaFasa 3
- SCRI Oncology Partners, Nashville
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1/2
- Research Site, Franklin · 17 mi jauh
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Mengambil pesertaFasa 1/2
- SCRI Oncology Partners, Nashville
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Mengambil pesertaFasa 1/2
- Vanderbilt University Medical Center, Nashville
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Mengambil pesertaFasa 3
- Sarah Cannon Research Institute SCRI, Nashville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Mengambil pesertaFasa 3
- SCRI Oncology Partners, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
Mengambil pesertaFasa 2
- SCRI Oncology Partners, Nashville
Kajian Limfoma Sel-B di bandar lain
- New York City, NY18 kajian
- Houston, TX16 kajian
- Chicago, IL13 kajian
- Philadelphia, PA11 kajian
- Rochester, MN10 kajian
- Milwaukee, WI9 kajian
- Baldwin Park, CA9 kajian
- Cleveland, OH9 kajian
- Boston, MA8 kajian
- Salt Lake City, UT8 kajian
- Washington, DC7 kajian
- Pittsburgh, PA7 kajian
Kajian lain di Nashville
- Kanser Paru-paru Bukan Sel Kecil97 kajian
- Kanser Payudara81 kajian
- Kanser Metastatik70 kajian
- Kanser Kolorektal69 kajian
- Kanser (semua jenis)65 kajian
- Kanser Ovari49 kajian
- Kanser Prostat43 kajian
- Kanser Paru-paru40 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher39 kajian
- Kanser Pankreas39 kajian
- Kanser Endometrium38 kajian
- Melanoma33 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.